Does Wegovy help with cravings — and how quickly?

Step 1: what happens in the brain when you take Wegovy

Most appetite medicines work only in the gut. Semaglutide goes further. GLP-1 receptors sit not just in the stomach and pancreas but in the hypothalamus, the brainstem, and the mesolimbic reward system, the same circuitry involved in the pleasure response to food. When semaglutide binds to those receptors, two things happen at once: the gut slows down (you feel fuller for longer after eating), and the brain's urgency signal around food quietens.

That second part is why people on Wegovy often describe thinking about food less, not just eating less. The persistent mental pull towards a biscuit, a second helping, or a late-night snack weakens. Sugar cravings, in particular, seem to be affected because high-sugar foods derive much of their appeal from dopamine-mediated reward, and GLP-1 signalling in the brain appears to dial that reward down, and if you want to understand why craving sugar on Wegovy is such a common experience, that page unpacks the mechanism in detail. You can read more about the mechanism on how Wegovy works if you want the full picture.

This is not a willpower top-up. It is a pharmacological shift in the signals your body sends. That distinction matters because it helps explain why some people find the change striking even before significant weight loss has occurred.

Step 2: when the craving reduction tends to kick in

The titration schedule matters here. Treatment begins at 0.25 mg weekly, a tolerability dose designed to let your system adjust rather than deliver the full therapeutic effect straight away. Most people do not notice a dramatic change in cravings at this stage. The dose climbs roughly every four weeks, through 0.5 mg, 1.0 mg, and 1.7 mg, up to the 2.4 mg maintenance dose.

For many people the shift becomes noticeable somewhere around the 1.0–1.7 mg phase, usually six to twelve weeks in. That said, some people feel a meaningful reduction in food preoccupation within the first fortnight; others find it takes until maintenance dose. If you started treatment just after a bank holiday or around payday when social eating spikes, the early weeks can feel like they are working against you even when the medicine is doing its job.

The semaglutide overview covers the full dose pathway and what to expect at each stage. The key point is patience: the titration exists for a reason, and most of the craving benefit builds as the dose does.

Step 3: what the evidence actually shows about cravings and sugar specifically

The STEP 1 trial (68 weeks, semaglutide 2.4 mg versus placebo, 1,961 adults with obesity) recorded not just weight change but patient-reported outcomes on appetite, hunger, and food preoccupation. Participants on semaglutide reported significantly lower scores on all three measures compared with placebo. Average body-weight reduction was around 15%, a figure cited by the NHS medicines page for semaglutide and established in the published trial.

On the question of sugar cravings specifically, the effect appears to be real but is not fully separated from appetite reduction overall in the published trial data. What practitioners observe, and what the evidence on whether Wegovy reduces cravings explores in more detail, is that sweet and highly processed foods lose their urgency first. Protein and plain foods are often reported to feel more satisfying relative to what they were before treatment. That shift in food preference, not just portion size, is part of how semaglutide supports lasting change.

NICE's appraisal of semaglutide for weight management, TA875, assessed the clinical evidence base and recommended it within specialist weight management services for eligible adults.

Step 4: what supports the effect, and what can limit it

Semaglutide reduces cravings; it does not eliminate them entirely for everyone, and it does not replace the practical groundwork of eating patterns, sleep and activity that support any weight-management programme. People who report the strongest craving reduction tend to pair the medicine with regular meals and adequate protein, partly because the slower gastric emptying works best when there is something to slow down.

Stress, poor sleep and habitual eating triggers can still produce urges even when the biological appetite signal is quieter. The medicine reduces the volume on those signals; building new habits turns that lower volume into lasting change. If you find cravings returning or stronger than expected, that is worth raising with your prescriber rather than adjusting the dose yourself.

Curious about what to expect once treatment is established? The guide to managing cravings on Wegovy covers practical strategies alongside the clinical picture. And if you are weighing up whether Wegovy is the right route for you, our Wegovy new customer page is the place to start, a real prescriber reviews your answers the same day and can talk through what treatment looks like for your specific situation.